- Home
- TSSI vs ENLV Comparison
TSSI vs ENLV Comparison
Compare TSSI & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TSSI | ENLV |
|---|---|---|
| Founded | 2004 | 2005 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 246.6M | 249.3M |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | TSSI | ENLV |
|---|---|---|
| Price | $7.79 | $1.10 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | ★ 1.1M | 427.3K |
| Earning Date | 03-26-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.63 | N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | ★ $234,837,000.00 | N/A |
| Revenue This Year | $54.04 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $43.18 | ★ N/A |
| Revenue Growth | ★ 91.66 | N/A |
| 52 Week Low | $5.63 | $0.66 |
| 52 Week High | $31.94 | $2.10 |
Technical Indicators
Market Signals| Indicator | TSSI | ENLV |
|---|---|---|
| Relative Strength Index (RSI) | 38.59 | 53.80 |
| Support Level | $7.86 | $1.10 |
| Resistance Level | $9.33 | $1.26 |
| Average True Range (ATR) | 0.82 | 0.08 |
| MACD | -0.25 | -0.01 |
| Stochastic Oscillator | 3.38 | 35.19 |
Price Performance
Historical ComparisonAbout TSSI TSS Inc.
TSS Inc provides various services for planning, design, development, and maintenance of mission-critical facilities and information infrastructure, as well as integration services. Its services consist of technology consulting, design and engineering, project management, systems integration, systems installation, facilities management, and IT procurement services. The activities are organized into two segments: Procurement, Systems Integration, and Facilities Management. It generates the majority of its revenue from the Procurement segment.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.